Abbott Laboratories (ABT)vsAnteris Technologies Global Corp. Common Stock (AVR)
ABT
Abbott Laboratories
$101.95
-1.36%
HEALTHCARE · Cap: $176.41B
AVR
Anteris Technologies Global Corp. Common Stock
$8.35
+0.60%
HEALTHCARE · Cap: $813.78M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 2077732% more annual revenue ($46.59B vs $2.24M). ABT leads profitability with a 11.7% profit margin vs 0.0%. ABT earns a higher WallStSmart Score of 54/100 (C-).
ABT
Buy54
out of 100
Grade: C-
AVR
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-37.5%
Fair Value
$74.13
Current Price
$101.95
$27.82 premium
Intrinsic value data unavailable for AVR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 2.1B in free cash flow
Revenue surging 63.3% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 47.5%
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Free Cash Flow. Revenue growth of 13.0% demonstrates continued momentum.
Bull Case : AVR
The strongest argument for AVR centers on Revenue Growth, Debt/Equity. Revenue growth of 63.3% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : AVR
The primary concerns for AVR are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
ABT profiles as a value stock while AVR is a hypergrowth play — different risk/reward profiles.
AVR carries more volatility with a beta of 0.73 — expect wider price swings.
AVR is growing revenue faster at 63.3% — sustainability is the question.
ABT generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (54/100 vs 33/100) and 13.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Anteris Technologies Global Corp. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Anteris Technologies Global Corp. The company is headquartered in Toowong, Australia.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?